Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Victor Moreno

Showing results (1-10 of 572) with videos related to

Pageof 58
Sort By:
Statistical Applications in Genetics and Molecular Biology|August 13, 2013
The mid p-value in exact tests for Hardy-Weinberg equilibriumJan Graffelman, Victor Moreno
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 14, 2022
GITR Antibodies in Cancer: Not Ready for Prime TimeTatiana Hernandez-Guerrero, Victor Moreno
BMC Medicine|April 18, 2015
Altered pathways and colorectal cancer prognosisVictor Moreno, Rebeca Sanz-Pamplona
Translational Lung Cancer Research|September 12, 2024
Are PD-1T TILs merely an expensive and unuseful whim as biomarker?Esther Garcia-Lorenzo, Victor Moreno
Translational Lung Cancer Research|May 17, 2023
Targeting the adenosine 2A receptor in non-small cell lung cancer: shooting with blank bullets?Esther Garcia-Lorenzo, Victor Moreno
Cancer Treatment Reviews|December 25, 2012
Thymoma and thymic carcinoma in the target therapies eraAngela Lamarca, Victor Moreno, Jaime Feliu
Oncotarget|August 8, 2023
CDK9 INHIBITORS: a promising combination partner in the treatment of hematological malignanciesDaniel Morillo, Gala Vega, Victor Moreno
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 11, 2021
Antidrug Antibodies and Drug Development: Challenges in the Immunotherapy EraBernard Doger de Spéville, Victor Moreno
Clinical and Experimental Rheumatology|November 11, 2024
Comment on: Red blood cell distribution width as a surrogate biomarker of damage and disease activity in patients with systemic lupus erythematosusVictor Moreno-Torres, Raquel Castejón Díaz
European Radiology|August 28, 2003
Selective use of low-osmolality contrast media in computed tomographyCarlos Valls, Eduard Andía, Anna Sánchez, et al.
Pageof 58

Showing results (1-10 of 572) with videos related to

Sort By:
Pageof 58
Statistical Applications in Genetics and Molecular Biology|August 13, 2013
The mid p-value in exact tests for Hardy-Weinberg equilibriumJan Graffelman, Victor Moreno
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 14, 2022
GITR Antibodies in Cancer: Not Ready for Prime TimeTatiana Hernandez-Guerrero, Victor Moreno
BMC Medicine|April 18, 2015
Altered pathways and colorectal cancer prognosisVictor Moreno, Rebeca Sanz-Pamplona
Translational Lung Cancer Research|September 12, 2024
Are PD-1T TILs merely an expensive and unuseful whim as biomarker?Esther Garcia-Lorenzo, Victor Moreno
Translational Lung Cancer Research|May 17, 2023
Targeting the adenosine 2A receptor in non-small cell lung cancer: shooting with blank bullets?Esther Garcia-Lorenzo, Victor Moreno
Cancer Treatment Reviews|December 25, 2012
Thymoma and thymic carcinoma in the target therapies eraAngela Lamarca, Victor Moreno, Jaime Feliu
Oncotarget|August 8, 2023
CDK9 INHIBITORS: a promising combination partner in the treatment of hematological malignanciesDaniel Morillo, Gala Vega, Victor Moreno
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 11, 2021
Antidrug Antibodies and Drug Development: Challenges in the Immunotherapy EraBernard Doger de Spéville, Victor Moreno
Clinical and Experimental Rheumatology|November 11, 2024
Comment on: Red blood cell distribution width as a surrogate biomarker of damage and disease activity in patients with systemic lupus erythematosusVictor Moreno-Torres, Raquel Castejón Díaz
European Radiology|August 28, 2003
Selective use of low-osmolality contrast media in computed tomographyCarlos Valls, Eduard Andía, Anna Sánchez, et al.
Pageof 58